Filing Details

Accession Number:
0001209191-19-017820
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-07 17:05:52
Reporting Period:
2019-03-05
Accepted Time:
2019-03-07 17:05:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1358762 Reata Pharmaceuticals Inc RETA Pharmaceutical Preparations (2834) 113651945
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1662321 Edward James Bass 2801 Gateway Drive
Suite 150
Irving TX 75063
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2019-03-05 2,631 $0.00 51,479 No 5 G Direct
Class A Common Stock Disposition 2019-03-05 5,852 $100.29 11,703 No 4 S Indirect By Bass Trust FBO James E. Bass
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Direct
No 4 S Indirect By Bass Trust FBO James E. Bass
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Class A Common Stock 41,902 Indirect By Bass Family Trust A
Footnotes
  1. A portion of the shares sold and reported herein is matchable under Section 16(b) of the Securities and Exchange Act of 1934 ("Section 16(b)"). The Reporting Person has voluntarily disgorged to the Issuer the Section 16(b) profit that resulted from the transaction reported herein.